Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular and Clinical Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9450 Online ISSN: 2049-9469
Journal Cover
September-2015 Volume 3 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2015 Volume 3 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Association between δ-aminolevulinate dehydratase G177C polymorphism and blood lead levels in brain tumor patients

  • Authors:
    • Mahmoud Mostafa Taha
    • Osama Abd El Aziz Gaber
    • Norhan Abdalla Sabbah
    • Abd Allah S Abd Elazem
  • View Affiliations / Copyright

    Affiliations: Department of Neurosurgery, Faculty of Medicine, Zagazig University, Zagazig 44512, Egypt, Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Zagazig 44512, Egypt, Department of Medical Biochemistry, Faculty of Medicine, Al‑Azhar University, Assiut 71511, Egypt
    Copyright: © Taha et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 995-1000
    |
    Published online on: June 25, 2015
       https://doi.org/10.3892/mco.2015.589
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

As the δ-aminolevulinic acid dehydratase (ALAD) G177C polymorphism affects the toxicokinetics of lead in the body, and the corresponding exposure to lead may increase the risk of adult brain tumors, we hypothesize that there is a possible association of the ALAD G177C genotype and the risk of brain tumors in human. Therefore, the aim of the present study was to clarify the role of the ALAD enzyme gene polymorphism at position G177C in the pathogenesis of brain tumors and its correlation to lead exposure. The ALAD gene polymorphism at position G177C was genotyped using the polymerase chain reaction with restriction fragment length polymorphism method and measured the blood lead level by atomic absorption in 81 brain tumor patients and compared the results with 81 controls. The frequency of the GC genotype (ALAD1‑2) was significantly increased in primary brain tumor patients compared to the control group. The genotype frequency of ALAD2 (ALAD1‑2 and ALAD2‑2) was significantly higher in the meningioma patients but was not significant in glioma patients. There was no significant difference in the number of patients and blood lead level when compared with the control. There was a significant increase when compared to ALAD1 regarding a mean value of the lead level. The genotyping of the ALAD G177C polymorphism in the present study revealed a significant association between ALAD2 and brain tumors. The ALAD G177C polymorphism may modify the lead kinetics in the blood, is associated with higher blood lead burden and may provide a biomarker of neurotoxic risk.
View Figures
View References

1 

Agency for Toxic Substances and Disease Registry (ATSDR), . Toxicological profile for lead. U.S. Department of Health and Human Services; Atlanta, GA USA: 1999

2 

IARC WG, . IARC monographs on the evaluation of carcinogenic risks to humans: inorganic and organic lead compounds. Vol. 87. World Health Organization; Lyon, France: 2006

3 

van Wijngaarden E and Dosemeci M: Brain cancer mortality and potential occupational exposure to lead: Findings from the National Longitudinal Mortality Study, 1979–1989. Int J Cancer. 119:1136–1144. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Navas-Acién A, Pollán M, Gustavsson P and Plato N: Occupation, exposure to chemicals and risk of gliomas and meningiomas in Sweden. Am J Ind Med. 42:214–227. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Cocco P, Heineman EF and Dosemeci M: Occupational risk factors for cancer of the central nervous system (CNS) among US women. Am J Ind Med. 36:70–74. 1999. View Article : Google Scholar : PubMed/NCBI

6 

Steenland K and Boffetta P: Lead and cancer in humans: Where are we now? Am J Ind Med. 38:295–299. 2000. View Article : Google Scholar : PubMed/NCBI

7 

Battistuzzi G, Petrucci R, Silvagni L, Urbani FR and Caiola S: delta-Aminolevulinate dehydrase: A new genetic polymorphism in man. Ann Hum Genet. 45:223–229. 1981. View Article : Google Scholar : PubMed/NCBI

8 

Fujita H, Nishitani C and Ogawa K: Lead, chemical porphyria, and heme as a biological mediator. Tohoku J Exp Med. 196:53–64. 2002. View Article : Google Scholar : PubMed/NCBI

9 

Shen XM, Wu SH, Yan CH, Zhao W, Ao LM, Zhang YW, He JM, Ying JM, Li RQ, Wu SM, et al: Delta-aminolevulinate dehydratase polymorphism and blood lead levels in Chinese children. Environ Res. 85:185–190. 2001. View Article : Google Scholar : PubMed/NCBI

10 

Klaassen CD: Heavy metals and heavy-metal antagonistsGoodman & Gilman's the pharmacological basis of therapeutics. Brunton LL, Lazo JS and Parker KL: McGraw Hill; New York, NY: pp. 1753–1775. 2006

11 

Villayandre BM, Paniagua MA, Fernández-López A and Calvo P: Effect of delta-aminolevulinic acid treatment on N -methyl-D-aspartate receptor at different ages in the rat brain. Brain Res. 1061:80–87. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Bellinger D, Hu H, Titlebaum L and Needleman HL: Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health. 49:98–105. 1994. View Article : Google Scholar : PubMed/NCBI

13 

Chia SE, Huijun Z, Theng TM and Yap E: Possibilities of newer ALAD polymorphism influencing human susceptibility to effects of inorganic lead on the neurobehavioral functions. Neurotoxicology. 28:312–317. 2007. View Article : Google Scholar : PubMed/NCBI

14 

Rajaraman P, Schwartz BS, Rothman N, Yeager M, Fine HA, Shapiro WR, Selker RG, Black PM and Inskip PD: Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults. Environ Health Perspect. 113:1209–1211. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Lee BK, Lee GS, Stewart WF, Ahn KD, Simon D, Kelsey KT, Todd AC and Schwartz BS: Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ Health Perspect. 109:383–389. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Miller DT, Paschal DC, Gunter EW, Stroud PE and D'Angelo J: Determination of lead in blood using electrothermal atomisation atomic absorption spectrometry with a L'vov platform and matrix modifier. Analyst (Lond). 112:1701–1704. 1987. View Article : Google Scholar

17 

Wrensch M, Minn Y, Chew T, Bondy M and Berger MS: Epidemiology of primary brain tumors: Current concepts and review of the literature. Neuro Oncol. 4:278–299. 2002. View Article : Google Scholar : PubMed/NCBI

18 

Benkmann HG, Bogdanski P and Goedde HW: Polymorphism of δ -aminolevulinic acid dehydratase in various populations. Hum Hered. 33:62–64. 1983. View Article : Google Scholar : PubMed/NCBI

19 

Hsieh LL, Liou SH, Chen YH, Tsai LC, Yang T and Wu TN: Association between aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan. J Occup Environ Med. 42:151–155. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Kelada SN, Shelton E, Kaufmann RB and Khoury MJ: Delta-aminolevulinic acid dehydratase genotype and lead toxicity: A HuGE review. Am J Epidemiol. 154:1–13. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Miyaki K, Lwin H, Masaki K, Song Y, Takahashi Y, Muramatsu M and Nakayama T: Association between a polymorphism of aminolevulinate dehydrogenase (ALAD) gene and blood lead levels in Japanese subjects. Int J Environ Res Public Health. 6:999–1009. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Rajaraman P, Stewart PA, Samet JM, Schwartz BS, Linet MS, Zahm SH, Rothman N, Yeager M, Fine HA, Black PM, et al: Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev. 15:2514–2520. 2006. View Article : Google Scholar : PubMed/NCBI

23 

Silbergeld EK: Facilitative mechanisms of lead as a carcinogen. Mutat Res. 533:121–133. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Montenegro MF, Barbosa F Jr, Sandrim VC, Gerlach RF and Tanus-Santos JE: Ethnicity affects the distribution of delta-aminolevulinic acid dehydratase (ALAD) genetic variants. Clin Chim Acta. 367:192–195. 2006. View Article : Google Scholar : PubMed/NCBI

25 

Fujihara J, Agusa T, Yasuda T, Soejima M, Kato H, Panduro A, Koda Y, Kimura-Kataoka K and Takeshita H: Ethnic variation in genotype frequencies of delta-aminolevulinic acid dehydratase (ALAD). Toxicol Lett. 191:236–239. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Scinicariello F, Murray HE, Moffett DB, Abadin HG, Sexton MJ and Fowler BA: Lead and delta-aminolevulinic acid dehydratase polymorphism: Where does it lead? A meta-analysis. Environ Health Perspect. 115:35–41. 2007. View Article : Google Scholar : PubMed/NCBI

27 

Lacourt A, Cardis E, Pintos J, Richardson L, Kincl L, Benke G, Fleming S, Hours M, Krewski D, McLean D, et al: INTEROCC case-control study: Lack of association between glioma tumors and occupational exposure to selected combustion products, dusts and other chemical agents. BMC Public Health. 13:340–351. 2013. View Article : Google Scholar : PubMed/NCBI

28 

Ziemsen B, Angerer J, Lehnert G, Benkmann HG and Goedde HW: Polymorphism of δ -aminolevulinic acid dehydratase in lead-exposed workers. Int Arch Occup Environ Health. 58:245–247. 1986. View Article : Google Scholar : PubMed/NCBI

29 

Fleming DE, Chettle DR, Wetmur JG, Desnick RJ, Robin JP, Boulay D, Richard NS, Gordon CL and Webber CE: Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers. Environ Res. 77:49–61. 1998. View Article : Google Scholar : PubMed/NCBI

30 

Wetmur JG, Kaya AH, Plewinska M and Desnick RJ: Molecular characterization of the human δ -aminolevulinate dehydratase 2 (ALAD2) allele: Implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet. 49:757–763. 1991.PubMed/NCBI

31 

Mahaffey K, McKinney J and Reigart JR: Lead and compoundsEnvironmental toxicants, human exposures and their health effects. 2nd. Lippmann M: John Wiley and Sons, Inc; New York, NY: pp. 481–521. 2000

32 

Shaik AP and Jamil K: A study on the ALAD gene polymorphisms associated with lead exposure. Toxicol Ind Health. 24:501–506. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Sobin C, Gutierrez M and Alterio H: Polymorphisms of delta-aminolevulinic acid dehydratase (ALAD) and peptide transporter 2 (PEPT2) genes in children with low-level lead exposure. Neurotoxicology. 30:881–887. 2009. View Article : Google Scholar : PubMed/NCBI

34 

Süzen HS, Duydu Y, Aydin A, Işimer A and Vural N: Influence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism on biomarkers of lead exposure in Turkish storage battery manufacturing workers. Am J Ind Med. 43:165–171. 2003. View Article : Google Scholar : PubMed/NCBI

35 

Yang Y, Wu J and Sun P: Effects of delta-aminolevulinic acid dehydratase polymorphisms on susceptibility to lead in Han subjects from southwestern China. Int J Environ Res Public Health. 9:2326–2338. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Taha MM, Gaber OA, Sabbah NA and Abd Elazem AS: Association between δ-aminolevulinate dehydratase G177C polymorphism and blood lead levels in brain tumor patients. Mol Clin Oncol 3: 995-1000, 2015.
APA
Taha, M.M., Gaber, O.A., Sabbah, N.A., & Abd Elazem, A.S. (2015). Association between δ-aminolevulinate dehydratase G177C polymorphism and blood lead levels in brain tumor patients. Molecular and Clinical Oncology, 3, 995-1000. https://doi.org/10.3892/mco.2015.589
MLA
Taha, M. M., Gaber, O. A., Sabbah, N. A., Abd Elazem, A. S."Association between δ-aminolevulinate dehydratase G177C polymorphism and blood lead levels in brain tumor patients". Molecular and Clinical Oncology 3.5 (2015): 995-1000.
Chicago
Taha, M. M., Gaber, O. A., Sabbah, N. A., Abd Elazem, A. S."Association between δ-aminolevulinate dehydratase G177C polymorphism and blood lead levels in brain tumor patients". Molecular and Clinical Oncology 3, no. 5 (2015): 995-1000. https://doi.org/10.3892/mco.2015.589
Copy and paste a formatted citation
x
Spandidos Publications style
Taha MM, Gaber OA, Sabbah NA and Abd Elazem AS: Association between δ-aminolevulinate dehydratase G177C polymorphism and blood lead levels in brain tumor patients. Mol Clin Oncol 3: 995-1000, 2015.
APA
Taha, M.M., Gaber, O.A., Sabbah, N.A., & Abd Elazem, A.S. (2015). Association between δ-aminolevulinate dehydratase G177C polymorphism and blood lead levels in brain tumor patients. Molecular and Clinical Oncology, 3, 995-1000. https://doi.org/10.3892/mco.2015.589
MLA
Taha, M. M., Gaber, O. A., Sabbah, N. A., Abd Elazem, A. S."Association between δ-aminolevulinate dehydratase G177C polymorphism and blood lead levels in brain tumor patients". Molecular and Clinical Oncology 3.5 (2015): 995-1000.
Chicago
Taha, M. M., Gaber, O. A., Sabbah, N. A., Abd Elazem, A. S."Association between δ-aminolevulinate dehydratase G177C polymorphism and blood lead levels in brain tumor patients". Molecular and Clinical Oncology 3, no. 5 (2015): 995-1000. https://doi.org/10.3892/mco.2015.589
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team